Provided by Tiger Trade Technology Pte. Ltd.

Axsome Therapeutics

210.63
+2.811.35%
Volume:428.39K
Turnover:89.97M
Market Cap:11.03B
PE:-55.89
High:211.22
Open:207.97
Low:205.76
Close:207.82
52wk High:260.19
52wk Low:112.90
Shares:52.38M
Float Shares:43.83M
Volume Ratio:0.81
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7685
EPS(LYR):-3.6821
ROE:-245.10%
ROA:-16.31%
PB:132.44
PE(LYR):-57.20

Loading ...

U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics

Reuters
·
Aug 11

Faster Revenue Growth With Wider Losses Might Change The Case For Investing In Axsome (AXSM)

Simply Wall St.
·
Aug 11

Movement Alert|Axsome Therapeutics Rises 5.01% in Regular Trading, Q2 Revenue Up 46% YoY as Stock Recovers Pre-Market Losses

Market Focus
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Aquestive Therapeutics (AQST) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Aug 11

Axsome Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 10

Sector Update: Healthcare Stocks Edge Higher Premarket Monday

MT Newswires Live
·
Aug 10

Axsome Therapeutics Shares Reverse Course Premarket; Last up 2.2%

THOMSON REUTERS
·
Aug 10

Heron Therapeutics Q2 Revenue Rises on Acute Care Growth, Withdraws 2026 Outlook

Reuters
·
Aug 10

CervoMed Q2 Net Loss Lower than Estimates as Costs Drop

Reuters
·
Aug 10

Axsome Therapeutics reports Q2 EPS (99c), consensus (85c)

TIPRANKS
·
Aug 10

Axsome Therapeutics Q2 Loss Widens, Revenue Increases

MT Newswires Live
·
Aug 10

Axsome Therapeutics Q2 Revenue Rises on Auvelity Growth

Reuters
·
Aug 10

Axsome Therapeutics Shares Down 8.4% Premarket After Q2 Revenue Miss

THOMSON REUTERS
·
Aug 10

Axsome Q2 FY26 Net Loss Widens to $51.3 Million; Net Product Revenue Climbs 46% to $218.4 Million Year over Year

Reuters
·
Aug 10

Stock Track | Axsome Therapeutics Plunges 5.99% in Pre-market After Q2 Earnings Miss Estimates

Stock Track
·
Aug 10

Earnings Flash (AXSM) Axsome Therapeutics Posts Q2 Loss $0.99 a Share, vs. FactSet Est of $0.89 Loss

MT Newswires Live
·
Aug 10

Axsome Therapeutics Q2 EPS $(0.99) Misses $(0.83) Estimate, Sales $218.400M Miss $221.230M Estimate

Benzinga Earnings
·
Aug 10

Axsome Therapeutics Q2 Net Income USD -51.314 Million

Reuters
·
Aug 10

Axsome Therapeutics Q2 EPS USD -0.99

THOMSON REUTERS
·
Aug 10

Axsome Therapeutics Q2 Operating Expenses USD 268.021 Million

THOMSON REUTERS
·
Aug 10